Rui Avelar

All filings by Rui Avelar on record concern Evolus, Inc. Over a trading history stretching from 10 August 2021 to 20 March 2026, the count stands at 18 filings.

No open-market purchase appears, only 10 sales worth €1.2M. Outside the open market, there are 7 share grants and 1 option exercise. 2026 to date brings no purchases and 1 sale.

On 20 March 2026 came the latest disclosure, an open-market sale for €13k in Evolus, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.